SHERP

Metastasis-Associated Protein S100A4 and p53 Predict Relapse in Curatively Resected Stage III and IV (M0) Gastric Cancer

Cited 0 time in webofscience Cited 0 time in scopus
Authors
Kim, Yu Jung; Kim, Min A; Im, Seock-Ah; Kim, Tae Min; Kim, Dong-Wan; Yang, Han-Kwang; Heo, Dae Seog; Lee, Kuhn-Uk; Choe, Kuk Jin; Kim, Noe Kyeong; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue
Issue Date
2007-12-20
Publisher
Taylor & Francis
Citation
Cancer Invest, 2008, 26, 152-158
Keywords
Gastric cancer; Relapse; Immunohistochemistry; S100A4; p53
Abstract
PURPOSE: Pathologic stage is the most important predictive factor of relapse in gastric cancer after curative resection. However, patients with the same stage often have different risks of relapse. Here, we investigated whether the expressions of molecular markers can supplement the current staging system in terms of relapse prediction. PATIENTS AND METHODS: One hundred and nine stage III or IV (M0) patients who had received curative gastrectomy followed by adjuvant 5-fluorouracil and cisplatin chemotherapy were included in this study. The expressions of molecular markers including p53, p27, COX-2, HER-2, EGFR, maspin, S100A4, E-cadherin, Sp1, and p97 were analyzed by immunohistochemistry in cancer and paired normal tissues. RESULTS: The overall relapse rate was 58.7%, and pathologic stage was a significant predictive factor of relapse (42% in stage IIIA, 48% in IIIB, 76% in IV, p = 0.005). Of the 10 markers examined, p53 and S100A4 were expressed only in tumor tissues, and S100A4 expression was significantly associated with a higher relapse rate (85% vs. 53%, p = 0.008). In multivariate analysis including tumor stage, S100A4 and p53 expression were independent predictive factors of relapse (relative risk, 6.98; 95% confidence interval [CI], 1.608-30.342, 3.49; 95% CI, 1.328-9.186, respectively). On comparing patients who expressed S100A4 or p53 with those who expressed neither, relapse rates were 58% vs. 25% in stage III (p = 0.011) and 95% vs. 59% in stage IV (M0) (p = 0.003). CONCLUSION: In addition to staging system, the expressions of S100A4 and p53 were significant predictive factors of relapse in gastric cancer after curative resection and adjuvant chemotherapy.
ISSN
0735-7907 (print)1532-4192 (online)
Language
English
URI
http://hdl.handle.net/10371/4609
DOI
https://doi.org/10.1080/07357900701518909
https://doi.org/10.1080/07357900701518909
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Pathology (병리학전공)Journal Papers (저널논문_병리학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse